Clinical Trials Directory

Trials / Completed

CompletedNCT04014699

Clinical Evaluation of Modified 2.2mm Microincision Phacoemulsification for Age-related Cataract

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
130 (actual)
Sponsor
Zhongshan Ophthalmic Center, Sun Yat-sen University · Academic / Other
Sex
All
Age
65 Years – 90 Years
Healthy volunteers
Accepted

Summary

This study is a single-center, parallel-group, randomized controlled trial with the following objectives: to compare the incidence of post-operative descemet membrane detachment (DMD) in phacoemulsification surgery between modified and conventional 2.2mm microincision.

Detailed description

2.2mm incision is considered an ideal incision size in phacoemulsification. However, DMD is a common and serious complication in 2.2mm microincision phacoemulsification for hard nucleus age-related cataract. DMD is originated from the incision in the operation. How to construct the appropriate incision shape and size for reducing the occurrence of DMD is an important problem to be solved urgently in phacoemulsification surgery. The investigators found that enlarging the internal incision could increase the range of motion of surgical instruments and reduce the friction of instruments to incision. Therefore,the incidence of DMD would be reduced. The investigators developed this technique, modified 2.2mm incision, to reduce the incidence of incision-site DMD and not to increase other incision related complications. In this trial, the investigators aim to compare modified and conventional 2.2mm incision with regard to safety and efficacy in reducing the incidence of DMD.

Conditions

Interventions

TypeNameDescription
PROCEDUREmodified 2.2mm microincisionenlarging the internal incision about 0.4mm for conventional 2.2mm coaxial microincision phacoemulsification
PROCEDUREconventional 2.2mm microincisionconventional 2.2mm coaxial microincision phacoemulsification

Timeline

Start date
2019-07-22
Primary completion
2019-10-22
Completion
2020-01-22
First posted
2019-07-10
Last updated
2020-09-16

Locations

1 site across 1 country: China

Source: ClinicalTrials.gov record NCT04014699. Inclusion in this directory is not an endorsement.